The role of the intestine as a target with a therapeutic role in people with neurodegenerative diseases
DOI:
https://doi.org/10.56294/saludcyt2023310Keywords:
Gut, Microbiota, Therapeutics, Neurodegenerative diseaseAbstract
There is a bidirectional exchange known as the gut-brain axis with several connections including the vagus nerve, the immune system, metabolites, and bacterial products. During dysbiosis, there is an alteration of the blood-brain barrier permeability and neuroinflammation. The objective of this review was to describe the role of the gut microbiota and its therapeutic role in neurodegenerative diseases. The gut microbiota-brain axis includes a set of microorganisms including common bacteria (Lactobacillus and S. aureus), fungi, and viruses that play an important role in gut function, such as barrier protection and preventing the passage of bacteria or pathogens from outside the gut, as well as metabolizing carbohydrates and producing vitamins K, B12, and B7. However, when the gut microbiota is altered due to stress, diet, or other factors, communication through ascending pathways can lead to alterations in the immune, endocrine, and nervous responses
References
1.Rutsch A, Kantsjö JB, Ronchi F. The Gut-Brain Axis: How Microbiota and Host Inflammasome Influence Brain Physiology and Pathology. Front Immunol. 2020;11:604179. https://doi.org/10.3389/fimmu.2020.604179
2. Fung TC. The microbiota-immune axis as a central mediator of gut-brain communication. Neurobiol Dis. 2020;136:104714. https://doi.org/10.1016/j.nbd.2019.104714
3. Kim YK, Shin C. The Microbiota-Gut-Brain Axis in Neuropsychiatric Disorders: Pathophysiological Mechanisms and Novel Treatments. Curr Neuropharmacol. 2018;16(5):559-73. https://doi.org/10.2174/1570159X15666170915141036
4. Ma Q. Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. J Neuroinflammation. 2019;16:53. https://doi.org/10.1186/s12974-019-1434-32019
5. Chudzik A, Orzyłowska A, Rola R, Stanisz GJ. Probiotics, Prebiotics and Postbiotics on Mitigation of Depression Symptoms: Modulation of the Brain–Gut–Microbiome Axis. Biomolecules. 2021;11(7):1000. https://doi.org/10.3390/biom11071000
6. Lacovich V, Espindola SL, Alloatti M, Devoto VP, Cromberg LE, Cˇarna ME, et al. Tau Isoforms Imbalance Impairs the Axonal Transport of the Amyloid Precursor Protein in Human Neurons. 2017;37(1):58–69. https://doi.org/10.1523/JNEUROSCI.2305-16.2016
7. Garre Olmo J. Epidemiología de la enfermedad de Alzheimer y otras demencias. Rev Neurol. 2018;66(11):377. https://doi.org/10.33588/rn.6611.2017519
8. Chen SJ, Lin CH. Gut microenvironmental changes as a potential trigger in Parkinson’s disease through the gut–brain axis. J Biomed Sci. 2022;29(1):54. https://doi.org/10.1186/s12929-022-00839-6
9. Gómez Eguílaz M, Ramón Trapero JL, Pérez Martínez L, Blanco JR. El eje microbiota-intestino-cerebro y sus grandes proyecciones. Rev Neurol. 2019;68(03):111. https://doi.org/10.1186/s12929-022-00839-6
10. Richarte V, Rosales K, Corrales M, Bellina M, Fadeuilhe C, Calvo E, et al. El eje intestino-cerebro en el trastorno por déficit de atención/hiperactividad: papel de la microbiota. Rev Neurol. 2018;66(S01):109. https://doi.org/10.33588/rn.66S01.2017525
11. Șchiopu CG, Ștefănescu C, Boloș A, Diaconescu S, Gilca-Blanariu GE, Ștefănescu G. Functional Gastrointestinal Disorders with Psychiatric Symptoms: Involvement of the Microbiome–Gut–Brain Axis in the Pathophysiology and Case Management. Microorganisms. 2022;10(11):2199. https://doi.org/10.3390/microorganisms10112199
12. Suganya K, Koo BS. Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and 19 Immune Pathways to Improve Brain Functions. Int J Mol Sci. 2020;21(20):7551. https://doi.org/10.3390/ijms21207551
13. Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res. 2019;29(10):787-803. https://doi.org/10.1038/s41422-019-0216-x
14. Takiishi T, Fenero CIM, Câmara NOS. Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tissue Barriers. 2017;5(4):e1373208. https://doi.org/10.1080/21688370.2017.1373208
15. Strandwitz P. Neurotransmitter modulation by the gut microbiota. Brain Res. agosto de 2018;1693:128-33. https://doi.org/10.1016/j.brainres.2018.03.015
16. Pavón FN, Lorigados PL. Neuroinflamación y Enfermedad de Parkinson. Cuba y Salud. 2019;14(3):44-49.
17. Mulak A. Brain-gut-microbiota axis in Parkinson’s disease. World J Gastroenterol. 2015;21(37):10609. https://doi.org/10.3748%2Fwjg.v21.i37.10609
18. Suganya K, Koo BS. Gut–Brain Axis: Role of Gut Microbiota on Neurological Disorders and How Probiotics/Prebiotics Beneficially Modulate Microbial and Immune Pathways to Improve Brain Functions. Int J Mol Sci. 2020;21(20):7551. https://doi.org/10.3390/ijms21207551
19. Cryan JF, O’Riordan KJ, Cowan CSM, Sandhu KV, Bastiaanssen TFS, Boehme M, et al. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019;99(4):1877-2013. https://doi.org/10.1152/physrev.00018.2018
20. Socała K, Doboszewska U, Szopa A, Serefko A, Włodarczyk M, Zielińska A, et al. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol Res. 2021;172:105840. https://doi.org/10.1016/j.phrs.2021.105840
21. Mederos LEA, Martínez WM, Hevia DG. Implicaciones de la microbiota intestinal en la etiología y terapéutica de la enfermedad de Parkinson. Revista Habanera de Ciencias Médicas. 2018;17(1): 48-57.
22. Lotti Mesa RL, Gutiérrez Gacel L. El eje microbiota-intestino-cerebro, futura diana terapéutica en enfermedades neurodegenerativas. Rev Neurol. 2019;69(01):43. https://doi.org/10.33588/rn.6901.2019159
23. Quigley EMM. Microbiota-Brain-Gut Axis and Neurodegenerative Diseases. Curr Neurol Neurosci Rep. 2017;17(12):94. https://doi.org/10.1007/s11910-017-0802-6
24. Tonini IG de O, Vaz DSS, Mazur CE. Eixo intestino-cérebro: relação entre a microbiota intestinal e desordens mentais. Res Soc Dev. 2020;9(7):e499974303. https://doi.org/10.33448/rsd-v9i7.4303
25. Wang L, Zhu L, Qin S. Gut Microbiota Modulation on Intestinal Mucosal Adaptive Immunity. J Immunol Res. 2019;2019:1-10. https://doi.org/10.1155%2F2019%2F4735040
26. Valdés Fernández MV, Rodríguez González M, Olivé González E. Comportamiento clínico de la sepsis nosocomial en CIREN, año 2006. Medwave. 2007; 7(7):2727. http://doi.org/10.5867/medwave.2007.07.2727
27. Castañeda GC. Microbiota intestinal y salud infantil. Rev Cubana Pediatr. 2018;90(1):94-110.
28. Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci. 2019;76(3):473-93. https://doi.org/10.1007/s00018-018-2943-4
29. Andreo Martínez P, García Martínez N, Quesada Medina J, Sánchez Samper EP, Martínez González AE. Candida spp. en la microbiota intestinal de las personas con autismo: revisión sistemática. Rev Neurol. 2019;68(01):1. https://doi.org/10.33588/rn.6801.2018129
30. Wang X, Sun G, Feng T, Zhang J, Huang X, Wang T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Res. 2019;29(10):787-803. https://doi.org/10.1038/s41422-019-0216-x
31. Pluta R, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ. Gut microbiota and pro/prebiotics in Alzheimer’s disease. Aging. 2020;12(6):5539-50. https://doi.org/10.18632%2Faging.102930
Published
Issue
Section
License
Copyright (c) 2023 María Paz Valdivieso Castro, Julio Cesar Ojeda Sánchez, Jorge Eduardo Ochoa Aucay (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
